Profile for Japan Patent: 2008503475
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Japan Patent: 2008503475
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| ⤷ Start Trial | Sep 24, 2029 | Abbvie | NAMENDA XR | memantine hydrochloride |
| ⤷ Start Trial | Sep 24, 2029 | Abbvie | NAMZARIC | donepezil hydrochloride; memantine hydrochloride |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
